As GLP-1 drugs demonstrate outcomes beyond weight loss, payers and health systems are increasingly evaluating them as tools for reducing downstream medical costs
Product Specifications Research Overview This page covers the 50mg presentation of GHK-Cu, the copper(II) complex of glycyl-L-histidyl-L-lysine, molecular formula CHCuNO, molecular weight 403.9 g/mol, CAS 89030-95-5
Every standard dose from 2.5mg through 10mg fits within a single 1 ml syringe
Sets of 1-5 reps with very heavy loads are effective for strength development but carry higher injury risk during a caloric deficit when recovery is compromised
You have access to FDA-approved weight loss medications, including both injectable and oral options
The concern regarding how GLP-1 medications affect birth control has to do with the fact that these medications significantly impact the rate of gastric emptying after meals